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Sarcoidal alopecia is a subtype of plaque-forming cutaneous sarcoidosis that may resemble discoid lupus
erythematosus (DLE). Because the clinical appearance of the two lesions is similar, the correct diagnosis
may be missed. The systemic involvement and progressive nature of sarcoidosis, make it important to
differentiate sarcoidal alopecia from DLE, so that proper treatment can be initiated and potential long-
term sequelae avoided. We present the case of a 57-year-old Taiwanese woman with sarcoidal alope-
cia of the scalp that mimicked DLE.
Copyright  2013, Taiwanese Dermatological Association.
Published by Elsevier Taiwan LLC. All rights reserved.Introduction
Sarcoidosis is an idiopathic systemic granulomatous disease, in
which noncaseating granulomatous inﬂammation can occur in any
organ. The skin is affected in about 25% of cases, and the majority of
cases occur in black women.1 The scalp is rarely involved, and the
inﬂammation may lead to cicatricial alopecia as a result of the
destruction of hair follicles by the granulomatous formation.1
Clinically, sarcoidosis may present as papules, nodules, or pla-
ques, and in some casesmay resemble discoid lupus erythematosus
(DLE) or necrobiosis lipoidica.2e6
Case report
A 57-year-old Taiwanese female had been very healthy most of her
life. However, over the past 4e5 years, she had developed painful
ulcerative wounds with alopecia on her frontoparietal scalp
(Figure 1). She had not been treated for the wounds or alopecia
prior to visiting our hospital. On examination, we saw several bean-
to coin-sized depressed ulcers surrounded by a violaceous to
erythematous hue, and telangiectasia on the right frontoparietal
scalp. No other skin lesions were noted.
DLE was suspected, and an incisional biopsy was performed. The
pathology report showed noncaseating granulomatous inﬂammatione no ﬁnancial or non-ﬁnancial
erials discussed in this article.
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iwanese Dermatological Associatioinvolving the superﬁcial and deep dermis (Figure 2). The granulomas
were composed of epithelioid cells and occasional giant cells, rich in
asteroid bodies. Results of direct immunoﬂuorescence tests for
immunoglobulin A (IgA), IgG, IgM, complement component 3 (C3),
ﬁbrinogen, and complement C1q were all negative. Periodic acid
Schiff, Fite, and acid-fast stains did not reveal any pathogens, and the
Venereal Disease Research Laboratory (VDRL) test was negative.
Therefore, the diagnosis of sarcoidal alopecia was conﬁrmed.
The immunologic proﬁles, including antinuclear antibody, anti-
extracted nuclear antigen (ENA) antibody, C3, and C4 were all
within normal ranges. However, plain chest ﬁlms and computed
tomography (CT) scans revealed pulmonary sarcoidosis with
lymphadenopathy (Figure 3). Lung function tests showed normal
spirometric values and diffusing capacity. Ophthalmologic exami-
nation ruled out any ocular involvement. The results of other blood
tests, such as complete blood cell counts, and measurement of
serum aspartate aminotransferase, alanine aminotransferase,
creatinine, blood urea nitrogen, sodium, potassium and calcium
levels, were all within normal limits.
Because the patient refused treatment with systemic cortico-
steroids, she was treated with oral hydroxychloroquine, 400 mg
daily, and intralesional injections of triamcinolone, 10 mg once a
month. She received a total of nine intralesional triamcinolone in-
jections from October 2009 to December 2011; these injections
were given on a monthly basis, except during the 18 months from
April 2010 to September 2011.
Because the patient had signiﬁcant overall improvement and
regrowth of hair, we discontinued local corticosteroid treatment in
January 2012. The dosage of oral hydroxychloroquine was also
tapered to 200 mg daily (beginning February 2012) and the diseasen. Published by Elsevier Taiwan LLC. All rights reserved.
Figure 1 Cicatricial alopecia with several bean- to coin-sized depressed ulcers. A
surrounding violaceous to erythematous hue can be seen on the patient’s right fron-
toparietal scalp. Figure 3 Plain chest ﬁlm shows bilateral hilar enlargement.
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aminations of the chest from 2009 to 2012 showed that the disease
had stabilized, and lung function tests remained normal.Figure 4 After treatment, the alopecia was nearly resolved.Discussion
Sarcoidal alopecia is a rare manifestation of cutaneous sarcoidosis
that predominantly affects black women.1 It is a form of secondary
cicatricial alopecia and can have variable morphologies. Most
commonly, cutaneous sarcoidosis on the frontoparietal facial re-
gion may extend into the scalp, which may lead to hair loss. Such
lesions are the type of sarcoidal alopecia that most mimics DLE
clinically.1e4
On the scalp, sarcoidosis can manifest as atrophic, erythema-
tous, scaly, or ulcerative areas of alopecia.1 The typical appearance
of DLE is of well-circumscribed, erythematous, scaly, atrophic pla-
ques, that may occasionally also be ulcerative.2 In both situations,
follicular plugging can be observed on dermoscopy.5 The differen-
tial diagnosis of sarcoidal alopecia and DLE can be made by histo-
pathologic examination. Sarcoidal alopecia shows classic naked
granulomas in the dermis.1e4 In contrast, DLE is characterized by
follicular plugging, epidermal atrophy, vacuolar degeneration of
basal keratinocytes, and basementmembrane thickening, as well as
superﬁcial and deep perivascular and periadnexal lymphocytic
inﬁltrates.2
Patients with sarcoidal alopecia almost always have other
cutaneous lesions, and the vast majority of cases will also demon-
strate systemic involvement.1 About 30% of patients with the initialFigure 2 Pathological examination revealed noncaseating granulomatous inﬂammation in
magniﬁcation 40, hematoxylin and eosin stain; (B) original magniﬁcation 100, hematoxform of cutaneous sarcoidosis will develop its systemic formwithin
months to several years of diagnosis.6 Therefore, it is recommended
that any patient with cutaneous sarcoidosis be screened for sys-
temic lesions, even if there are no clinical complaints of systemic
involvement at initial visits. Several diagnostic studies can be per-
formed during the workup of sarcoidosis, including chest ﬁlms,
chest CT scans, and pulmonary function tests.
A review of the English literature revealed 47 reported cases of
scalp sarcoidosis, including ours.1,3,7e16 In these studies, patients
were predominantly female (35/40). Where race was mentioned,volving superﬁcial and deep dermis. Many asteroid bodies were found. (A) Original
ylin and eosin stain.
Table 1 A comparison of sarcoidal alopecia and discoid lupus erythematosus (DLE).
Sarcoidal alopecia DLE
Epidemiology Women > men
Blacks
Women > men
Blacks
Clinical features Atrophic, red, scaling or ulcerative areas of alopecia
A rare manifestation of cutaneous sarcoidosis
Frequent extracutaneous involvement; the
lung is the most frequently involved site
Relatively poor response to treatments
Erythematous scaly plaques with follicular plugs, telangiectasia, atrophy
and pigment changes; activity in the center of the alopecic patch
Frequently noted on the face, scalp, ears, V-neck area, and extensor sides of arms
5% of patients presenting with classic DLE lesions subsequently develop evidence of SLE
With treatment, skin disease can be largely controlled
Histopathology Noncaseating granulomas in the
dermis, with destruction of hair follicles and ﬁbrosis
Lymphocytic inﬁltrate centered on infundibulum and isthmus
Interfollicular epidermal inﬂammation and thickened basement membrane
Interface dermatitis (vacuolar > lichenoid)
Superﬁcial and deep perivascular and perieccrine inﬂammation
Dermal mucin
DIF: granular linear IgG and C3 along the basement membrane
Therapy Topical  intralesional corticosteroids
Prednisone, hydroxychloroquine, methotrexate
Inﬂiximab
Topical  intralesional corticosteroids
Hydroxychloroquine, prednisone, topical tacrolimus, tazarotene, imiquimod
Isotretinoin
DIF ¼ direct immunoﬂuorescence; SLE ¼ systemic lupus erythematosus.
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of the patients (32 of 37) exhibited extracutaneous involvement,
and the lung was the most frequently involved site. Other extrac-
utaneous manifestations included lymphadenopathies (18 of 37
patients), musculoskeletal involvement (4 of 37 patients), hep-
atosplenomegaly (3 of 37 patients), and ocular involvement (2 of 37
patients).
Our review of cases documented diverse morphologies of scalp
sarcoidosis, including papules, nodules, indurative plaques, scales,
and ulcers. Most of these cases showed scarring alopecia, but some
cases of non-scarring alopecia have also been reported.1,3 Sarcoidal
alopecia may resemble DLE, lichen planopilaris (follicular lichen
planus), pseudopelade of Brocq (alopecia cicatrisata), necrobiosis
lipoidica, morphea or alopecia neoplastica. DLE is the most
confusing form. A comparison of the features of sarcoidal alopecia
and DLE is presented in Table 1.
Given the limited clinical data available, it is difﬁcult to draw
deﬁnite conclusions about responses to therapy, prognosis, and
outcome for patients with sarcoidal alopecia. Some authors have
reported having poor responses with multiple treatments,
including intralesional and/or systemic corticosteroids, antimalar-
ials, and azathioprine. The overall response to treatment appears
poor, but more information and analysis of more cases are needed
before accurate conclusions can be made.
The standard treatment for sarcoidosis is systemic corticoste-
roids. Topical corticosteroids are often ineffective in treating sar-
coidal alopecia, because of their inadequate depth of penetration
into the skin. Combination antimalarial therapy (hydroxy-
chloroquine plus quinacrine or chloroquine plus quinacrine) can be
valuable after single-agent antimalarial therapy has failed.1 The
rationale of using antimalarial therapy in cutaneous sarcoidosis is
based on the ability of these agents to inhibit antigenprocessing and
presentation by antigen presenting cells to CD4þ T cells.17 Antima-
larialsmay raise the pHwithin lysosomes, thus preventing assembly
of major histocompatibility complex (MHC)epeptide complexes
and transport to the cell’s surface. Without antigen processing and
presentation viaMHCepeptide complexes, noTcells are activated to
promote granuloma formation.17 Antimalarial agents have a rela-
tively long history of use in the treatment of sarcoidosis, and are
regarded as standard therapy. Typically, they are used in combina-
tion with corticosteroids, or singly for patients in whom cortico-
steroids are undesirable or unnecessary for long-term treatment.
Based on reported clinical experience, the primary beneﬁt of anti-
malarials appears to be their ability to suppress the formation of
cutaneous lesions.18 In our case, due to the disﬁgurement from the
scalp lesions and our patient’s hesitance to be treatedwith systemiccorticosteroids, we administered hydroxychloroquine and intrale-
sional corticosteroids simultaneously.
DLE and several other diseases that resemble cutaneous
sarcoidosis are relatively benign. Because of its characteristic clin-
ical appearance and infrequent association with systemic lupus
erythematosus, therapy for DLE is often administered without
histologic conﬁrmation of lesions.2 This precludes identiﬁcation of
its close clinical simulation, cutaneous sarcoidosis. In our practice,
we stress the importance of performing a skin biopsy to conﬁrm the
diagnosis of DLE on the scalp and to exclude sarcoidal alopecia.
Because of the systemic and progressive nature of sarcoidosis, it is
critical that this distinction is made and that the patient be treated
accordingly.2 Even though our patient did not receive any systemic
corticosteroid treatment because of her personal preference, the
identiﬁcation of sarcoidosis did help; disease monitoring would
enable us to provide appropriate treatment, should the disease
progress.
Cicatricial alopecia presents a diagnostic challenge for clinicians,
particularly because the lesions of cutaneous sarcoidosis of the
scalp may resemble DLE. Pathological examination is required to
make the correct diagnosis, which then leads to effective treatment.
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